Dr. Moshiyakhov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Trenton Rd
Browns Mills, NJ 08015Phone+1 609-893-6611Fax+1 609-893-6038
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Cardiovascular Disease, 2004 - 2007
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2001 - 2004
Albert Einstein College of MedicineClass of 2001
Certifications & Licensure
NJ State Medical License 2004 - 2025
NY State Medical License 2010 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 2 citationsShared Care to Destination Therapy Left Ventricular Assist Device Site: a Novel Strategy to Start a Successful Mechanical Circulatory Support Program.Meet Shah, Yamama Hafeez, Paul Burns, Yoshiya Toyoda, Mark Moshiyakhov
Current Cardiology Reports. 2021-07-15 - 3 citationsThe evolution of dual antiplatelet therapy in the setting of acute coronary syndrome: ticagrelor versus clopidogrel.Frank Amico, Angela Amico, Jennifer Mazzoni, Mark Moshiyakhov, William Tamparo
Postgraduate Medicine. 2016-01-01 - 19 citationsRegadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis.David H. Hsi, Rajeev Marreddy, Mark Moshiyakhov, Ulrich Luft
Journal of Nuclear Cardiology. 2013-03-05
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
